Bank of New York Mellon’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$832K Buy
402,111
+73,769
+22% +$153K ﹤0.01% 3209
2025
Q1
$722K Sell
328,342
-12,368
-4% -$27.2K ﹤0.01% 3232
2024
Q4
$521K Sell
340,710
-29
-0% -$44 ﹤0.01% 3481
2024
Q3
$678K Sell
340,739
-108,473
-24% -$216K ﹤0.01% 3338
2024
Q2
$1.57M Buy
449,212
+113,655
+34% +$398K ﹤0.01% 2932
2024
Q1
$929K Sell
335,557
-68,813
-17% -$191K ﹤0.01% 3190
2023
Q4
$687K Buy
404,370
+50,975
+14% +$86.7K ﹤0.01% 3378
2023
Q3
$364K Buy
353,395
+19,345
+6% +$19.9K ﹤0.01% 3709
2023
Q2
$387K Sell
334,050
-1,179
-0.4% -$1.37K ﹤0.01% 3712
2023
Q1
$506K Sell
335,229
-14,186
-4% -$21.4K ﹤0.01% 3485
2022
Q4
$874K Buy
349,415
+1,779
+0.5% +$4.45K ﹤0.01% 3257
2022
Q3
$1.47M Buy
347,636
+36,285
+12% +$153K ﹤0.01% 3020
2022
Q2
$869K Buy
311,351
+6,618
+2% +$18.5K ﹤0.01% 3289
2022
Q1
$1.74M Buy
304,733
+5,882
+2% +$33.7K ﹤0.01% 3013
2021
Q4
$2.73M Sell
298,851
-32,986
-10% -$301K ﹤0.01% 2798
2021
Q3
$3.55M Buy
331,837
+32,251
+11% +$345K ﹤0.01% 2663
2021
Q2
$4.65M Sell
299,586
-40,888
-12% -$635K ﹤0.01% 2534
2021
Q1
$5.52M Sell
340,474
-14,891
-4% -$241K ﹤0.01% 2407
2020
Q4
$7.52M Sell
355,365
-2,749
-0.8% -$58.2K ﹤0.01% 2157
2020
Q3
$5.31M Sell
358,114
-11,045
-3% -$164K ﹤0.01% 2183
2020
Q2
$5.43M Buy
369,159
+13,604
+4% +$200K ﹤0.01% 2173
2020
Q1
$4.17M Sell
355,555
-7,799
-2% -$91.6K ﹤0.01% 2165
2019
Q4
$8.54M Buy
363,354
+28,982
+9% +$681K ﹤0.01% 2068
2019
Q3
$6.19M Buy
334,372
+24,602
+8% +$455K ﹤0.01% 2175
2019
Q2
$5.76M Buy
309,770
+12,030
+4% +$224K ﹤0.01% 2260
2019
Q1
$7.28M Sell
297,740
-325
-0.1% -$7.94K ﹤0.01% 2148
2018
Q4
$7.73M Sell
298,065
-15,247
-5% -$396K ﹤0.01% 2057
2018
Q3
$9.92M Buy
313,312
+13,928
+5% +$441K ﹤0.01% 2032
2018
Q2
$11.6M Buy
299,384
+19,966
+7% +$776K ﹤0.01% 1941
2018
Q1
$7.71M Buy
279,418
+78,719
+39% +$2.17M ﹤0.01% 2122
2017
Q4
$3.63M Sell
200,699
-3,296
-2% -$59.7K ﹤0.01% 2503
2017
Q3
$3.3M Sell
203,995
-862
-0.4% -$13.9K ﹤0.01% 2540
2017
Q2
$2.84M Buy
204,857
+14,086
+7% +$195K ﹤0.01% 2634
2017
Q1
$2.86M Buy
190,771
+40,657
+27% +$610K ﹤0.01% 2627
2016
Q4
$1.97M Buy
150,114
+182
+0.1% +$2.39K ﹤0.01% 2864
2016
Q3
$2.58M Buy
149,932
+1,946
+1% +$33.5K ﹤0.01% 2605
2016
Q2
$2.67M Buy
147,986
+4,579
+3% +$82.7K ﹤0.01% 2548
2016
Q1
$2.72M Sell
143,407
-4,066
-3% -$77.2K ﹤0.01% 2475
2015
Q4
$3.94M Buy
147,473
+27,004
+22% +$721K ﹤0.01% 2347
2015
Q3
$2.94M Buy
120,469
+5,441
+5% +$133K ﹤0.01% 2509
2015
Q2
$3.58M Sell
115,028
-36,151
-24% -$1.13M ﹤0.01% 2562
2015
Q1
$2.2M Buy
151,179
+45,618
+43% +$664K ﹤0.01% 2794
2014
Q4
$1.06M Sell
105,561
-2,030
-2% -$20.4K ﹤0.01% 3269
2014
Q3
$896K Buy
107,591
+23,321
+28% +$194K ﹤0.01% 3353
2014
Q2
$1.04M Buy
+84,270
New +$1.04M ﹤0.01% 3286